Home › Funds › Aisling Capital Management LP › GLUE

Aisling Capital Management LP position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Aisling Capital Management LP reported holding 1,555,664 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$18.6M, representing 6.20% of its reported portfolio and ranking #4 among its reported holdings. Aisling Capital Management LP has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.56M sh
Reported value held$18.56M
Portfolio Weight6.20%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aisling Capital Management LP's GLUE position evolved

Aisling Capital Management LP first disclosed a stake in GLUE in Q3 2023 at 1,472,331 shares (US$7.1M). The position peaked in Q2 2026 at 1,555,664 shares, worth US$37.6M. Across 13 filings, Aisling Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 1,555,664 shares valued at US$18.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.47M $7.05M New
Q4 2023 1.47M $8.32M Hold
Q1 2024 1.47M $10.38M Hold
Q2 2024 1.47M $5.51M Hold
Q3 2024 1.47M $7.80M Hold
Q4 2024 1.47M $10.22M Hold
Q1 2025 1.47M $6.83M Hold
Q2 2025 1.47M $6.64M Hold
Q3 2025 1.47M $10.91M Hold
Q4 2025 1.47M $23.09M Hold
Q1 2026 1.56M $25.59M Add
Q2 2026 1.56M $37.65M Hold
Q3 2026 1.56M $18.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 65 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Aisling Capital Management LP held GLUE?

Aisling Capital Management LP has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aisling Capital Management LP's current position in GLUE?

As of Q3 2026, Aisling Capital Management LP holds 1.56M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $18.56M, representing 6.20% of its reported portfolio and ranking #4.

Has Aisling Capital Management LP been buying or selling GLUE?

In the latest 13F filing (Q3 2026), Aisling Capital Management LP held unchanged its position in GLUE. The position peaked in Q2 2026 at 1.56M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.